Scinovex
article Open AccessTop 1% cited

Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

Bioorganic & Medicinal Chemistry Letters · 2001 · Vol. 11(14) · pp. 1911–1914
Andrew BarkerKeith H. GibsonWalter GrundyAndrew A. GodfreyJeffrey J BarlowMark P. HealyJ.R. WoodburnSusan AshtonBrenda J CurryL. ScarlettLianne HenthornLaura M. Richards
HER2/EGFR in Cancer ResearchQuinazolinone synthesis and applicationsSynthesis and biological activityTyrosine kinaseEpidermal growth factor receptorChemistryPharmacologyEpidermal growth factorGrowth factor receptorTyrosine-kinase inhibitorPlatelet-derived growth factor receptorPharmacokineticsCancer
Citations
559
FWCI
11.79
field-weighted impact
References
8
Percentile
99%
vs. same field & year
Citations per year
Cited by
Fluorine in medicinal chemistry
Chemical Society Reviews · 2007 · 7,325 citations
Synthesis of quinazolinones and quinazolines
Tetrahedron · 2005 · 623 citations
Epidermal growth factor receptor mutations in lung cancer
Nature reviews. Cancer · 2007 · 3,115 citations
How were new medicines discovered?
Nature Reviews Drug Discovery · 2011 · 1,768 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.